Cite
HARVARD Citation
Reenaers, C. et al. (n.d.). P723 Effectiveness and persistence of vedolizumab in patients with Inflammatory bowel Disease: Results from the Belgian REal-LIfe study with VEdolizumab (Be-RELIVE). Journal of Crohn's and colitis. pp. S476-S477. [Online].